Projects per year
Fingerprint
Dive into the research topics where Christopher Broder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
Geisbert, T. W., Schaefer, B. B., Broder, C., Golovko, G., Crowe, J. E., Xu, K. K., Zeitlin, L., Falo, L. L. D. & Cross, R. W.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
30/07/24 → 30/06/27
Project: Research
-
RP2: Vaccines and antibodies to henipavirus
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
1/03/24 → 28/02/25
Project: Research
-
-
Advancement of Vaccines and Therapies for Henipaviruses
Broder, C., Crowe, J. E., Eldridge, J. H., Geisbert, T. W. & Zeitlin, L.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
20/03/19 → 29/02/24
Project: Research
-
Core A - Administrative Core
Broder, C. C. & Broder, C.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
20/03/19 → 29/02/24
Project: Research
-
A recombinant Cedar virus preclinical model that recapitulates neurological features of henipavirus disease
Huaman, C., Clouse, C., Rader, M., Strazzella, A. M., King, J., Santorella, E. M., Yan, L., Bai, S., Gunn, B. M., Amaya, M., Broder, C. C. & Schaefer, B. C., 17 Oct 2025, In: iScience. 28, 10, 113571.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Characteristics and Outcomes of Cardiac Findings in Young Persons Following SARS-CoV-2 Infection
EPICC COVID-19 Cohort Study Group, 1 Apr 2025, In: Pediatric Infectious Disease Journal. 44, 4, p. 342-345 4 p.Research output: Contribution to journal › Article › peer-review
-
Development and Validation of a Differentiating Infected from Vaccinated Animals (DIVA) Enzyme-Linked Immunosorbent Assay (ELISA) Strategy for Distinguishing Between Hendra-Infected and Vaccinated Horses
McNabb, L., McMahon, A., Woube, E. G., Agnihotri, K., Colling, A., Broder, C. C., Kucinskaite-Kodze, I., Petraityte-Burneikiene, R., Bowden, T. R. & Halpin, K., Mar 2025, In: Viruses. 17, 3, 354.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of a VSV-Hantavirus based screening platform to identify anti-hantavirus neutralizing human nanobodies.
Amaya, M., Dharmavaratha, P., Jays, A., Dimitrov, A. S., Broder, C., Leland, P. & Xu, J., 2025, (In preparation).Research output: Contribution to conference › Poster › peer-review
-
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Pigeaud, D. D., Fenton, K. A., Turcinovic, J., Borisevich, V., Agans, K. N., Deer, D. J., Harrison, M. B., Fears, A. C., Dobias, N. S., Prasad, A. N., Smith, I. L., Williams, D. T., Woolsey, C. B., Broder, C. C., Cross, R. W. & Geisbert, T. W., 2025, In: Emerging Microbes and Infections. 14, 1, 2544735.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
CEPI Recognizes USU-Developed MAb Against Nipah Virus as a Top Innovation for Force Health Protection
25/04/25
1 item of Media coverage
Press/Media
-
CEPI RECOGNIZES USU-DEVELOPED MAB AGAINST NIPAH VIRUS AS A TOP INNOVATION FOR FORCE HEALTH PROTECTION
24/04/25
1 item of Media coverage
Press/Media
-
Breakthrough Discovery: New Treatment Offers Hope Against Deadly Nipah Virus
31/12/24
1 item of Media coverage
Press/Media
-
Studies from Uniformed Services University of the Health Sciences Further Understanding of Chlamydia (Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model)
Ann Jerse, George Liechti & Christopher Broder
3/12/24
1 item of Media coverage
Press/Media
-
UTMB Awarded a $15.6 Million/year NIH Grant for Three Years of Vaccine Development With Partners
17/09/24
1 item of Media coverage
Press/Media